Amneal exenatide injection pens recalled for possible missing medication
Some prefilled pens of Amneal Exenatide Injection may contain no medication due to a defective delivery system. This affects lot AP250095A (expiration 2/28/2027). Patients relying on these pens may not receive their intended dose.
From the FDA notice · Read the official notice ↗ · All Amneal Pharmaceuticals recalls
What to do
- Check if your Exenatide Injection matches lot AP250095A (expiration 2/28/2027).
- Do not use the pen if you suspect it is defective or empty.
- Contact your pharmacy or doctor for a replacement or alternative diabetes medication.
- Report any problems with this medication to the FDA at 1-888-SAFEMEDS or online at fda.gov/medwatch.
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 5,694 pens
- Illnesses reported
- None reported
- Manufactured in
- 50 Horseblock Rd, Brookhaven, NY, United States
- Classification
- Class II
- Recall number
- D-0868-2026
In the FDA's words
- Description
- Exenatide Injection, USP, 250 mcg/mL, 1.2 mL per prefilled pen, Rx Only, Subcutaneous Use Only, For Single Patient Use Only, Manufactured by: Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad 382213, India; Distributed by: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC 70121-1685-1 Defective Delivery System: Possibility of no medication in the prefilled pen. Lot #: AP250095A, Exp 2/28/2027 Distribution: USA Nationwide Affected quantity: 5,694 pens
- Hazard
- Defective Delivery System: Possibility of no medication in the prefilled pen.